American Century Companies’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
+12,203
New +$799K ﹤0.01% 2333
2025
Q3
– Sell
-19,526
Closed -$1.12M – 2783
2025
Q2
$1.12M Buy
19,526
+14,037
+256% +$1.13M ﹤0.01% 2244
2025
Q1
$594K Buy
+5,489
New +$478K ﹤0.01% 2445
2024
Q2
– Sell
-1,109
Closed -$169K – 2879
2024
Q1
$169K Buy
1,109
+55
+5% +$9.15K ﹤0.01% 2787
2023
Q4
$331K Buy
1,054
+211
+25% +$76.4K ﹤0.01% 2524
2023
Q3
$374K Buy
843
+25
+3% +$11.3K ﹤0.01% 2374
2023
Q2
$354K Buy
818
+141
+21% +$79.2K ﹤0.01% 2341
2023
Q1
$395K Buy
677
+45
+7% +$25.2K ﹤0.01% 2203
2022
Q4
$255K Buy
632
+187
+42% +$87.7K ﹤0.01% 2267
2022
Q3
$261K Buy
+445
New +$266K ﹤0.01% 2158

Other funds holding AGL

American Century Companies's AGL Position: Q2 2026 in Review

American Century Companies opened a new position in Agilon Health (AGL) in Q2 2026: 12,203 shares worth $1.31M. The stake represents ﹤0.01% of the portfolio and ranks #2333 among its holdings. This is a return to the name: American Century Companies previously reported a position in AGL as recently as Q2 2025.

American Century Companies first reported a position in AGL in Q3 2022 and has held it in 10 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • American Century Companies held 12,203 shares of Agilon Health worth $1.31M as of Q2 2026.
  • Agilon Health was a new American Century Companies position in Q2 2026.
  • Agilon Health made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2333 holding.
  • American Century Companies first reported a position in Agilon Health in Q3 2022 and has held it in 10 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.